Recurrent Ischemic Lesions after Acute Atherothrombotic Stroke: Clopidogrel Plus Aspirin Versus Aspirin Alone

Stroke

Volumn 47, Issue 9, 2016, Pages 2323-2330

  Hong, Keun Sik ^a   Lee, Seung Hoon ^b   Kim, Eung Gyu ^a,b   Cho, Ki Hyun ^d   Chang, Dae Il ^e   Rha, Joung Ho ^f   Bae, Hee Joon ^g   Lee, Kyung Bok ^h   Kim, Dong Eog ⁱ   Park, Jong Moo ^j   Kim, Hahn Young ^k   Cha, Jae Kwan ^l   Yu, Kyung Ho ^m   Lee, Yong Seok ⁿ   Lee, Soo Joo ^o   Choi, Jay Chol ^p   Cho, Yong Jin ^a   Kwon, Sun U ^q   Kim, Gyeong Moon ^r   Sohn, Sung Il ^s   Park, Kwang Yeol ^t   Kang, Dong Wha ^q   Sohn, Chul Ho ^c   Lee, Jun ^u   Yoon, Byung Woo ^b   more..

^a Inje University   (South Korea)

^b Seoul National University Hospital   (South Korea)

^c Department of Diagnostic Radiology ^*  (South Korea)

^d Chonnam National University Medical School   (South Korea)

^e Kyung Hee University College of Medicine   (South Korea)

^f Inha University Hospital   (South Korea)

^g Seoul National University Bundang Hospital   (South Korea)

^h Soonchunhyang University College of Medicine   (South Korea)

ⁱ Dongguk University   (South Korea)

^j Eulji General Hospital   (South Korea)

^k Konkuk University Hospital   (South Korea)

^l Dong A University College of Medicine   (South Korea)

^m Hallym University   (South Korea)

ⁿ Seoul National University Boramae Hospital   (South Korea)

^o Eulji University   (South Korea)

^p Jeju National University   (South Korea)

^q Asan Medical Center   (South Korea)

^r Samsung Medical Center   (South Korea)

^s Dongsan Medical Center   (South Korea)

^t Chung Ang University College of Medicine   (South Korea)

^u Yeungnam University Hospital   (South Korea)

more..

Author keywords

antiplatelet drugs; aspirin; atherosclerosis; clinical trial, randomized; clopidogrel; recurrence; stroke

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HEMOGLOBIN; PLACEBO; ANTITHROMBOCYTIC AGENT; TICLOPIDINE;

ACUTE ATHEROTHROMBOTIC STROKE; ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; BRAIN ATHEROSCLEROSIS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; COMBINATION DRUG THERAPY; COMPARATIVE STUDY; CONTROLLED STUDY; DISABILITY; DOUBLE BLIND PROCEDURE; DRUG SAFETY; FEMALE; FOLLOW UP; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPOVOLEMIC SHOCK; INTRAOCULAR HEMORRHAGE; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTICENTER STUDY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SIDE EFFECT; TREATMENT DURATION; TREATMENT OUTCOME; VASCULAR DISEASE; ANALOGS AND DERIVATIVES; ATHEROSCLEROSIS; BRAIN; CLINICAL TRIAL; COMPLICATION; DIAGNOSTIC IMAGING; MIDDLE AGED; SECONDARY PREVENTION; STROKE; THROMBOSIS;

AGED; ASPIRIN; ATHEROSCLEROSIS; BRAIN; BRAIN ISCHEMIA; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; SECONDARY PREVENTION; STROKE; THROMBOSIS; TICLOPIDINE;

EID: 84978711047     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.115.012293     Document Type: Article

References (25)

1. Diener HC, Bogousslavsky J, Brass LM, Cimminiello C, Csiba L, Kaste M, et al; MATCH Investigators. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet. 2004;364:331-337. doi: 10.1016/S0140-6736(04)16721-4.
2. Sacco RL, Diener HC, Yusuf S, Cotton D, Ounpuu S, Lawton WA, et al; PRoFESS Study Group. Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. N Engl J Med. 2008;359:1238-1251. doi: 10.1056/NEJMoa0805002.
3. Benavente OR, Hart RG, McClure LA, Szychowski JM, Coffey CS, Pearce LA. Effects of clopidogrel added to aspirin in patients with recent lacunar stroke. N Engl J Med. 2012;367:817-825.
4. Lee M, Saver JL, Hong KS, Rao NM, Wu YL, Ovbiagele B. Riskbenefit profile of long-term dual- versus single-antiplatelet therapy among patients with ischemic stroke: a systematic review and meta-analysis. Ann Intern Med. 2013;159:463-470. doi: 10.7326/0003-4819-159-7-201310010-00006.
5. Wang Y, Wang Y, Zhao X, Liu L, Wang D, Wang C, et al; CHANCE Investigators. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med. 2013;369:11-19. doi: 10.1056/ NEJMoa1215340.
6. Wong KS, Wang Y, Leng X, Mao C, Tang J, Bath PM, et al. Early dual versus mono antiplatelet therapy for acute non-cardioembolic ischemic stroke or transient ischemic attack: an updated systematic review and meta-analysis. Circulation. 2013;128:1656-1666. doi: 10.1161/ CIRCULATIONAHA.113.003187.
7. Lovett JK, Coull AJ, Rothwell PM. Early risk of recurrence by subtype of ischemic stroke in population-based incidence studies. Neurology. 2004;62:569-573.
8. Kang DW, Latour LL, Chalela JA, Dambrosia J, Warach S. Early ischemic lesion recurrence within a week after acute ischemic stroke. Ann Neurol. 2003;54:66-74. doi: 10.1002/ana.10592.
9. Bal S, Patel SK, Almekhlafi M, Modi J, Demchuk AM, Coutts SB. High rate of magnetic resonance imaging stroke recurrence in cryptogenic transient ischemic attack and minor stroke patients. Stroke. 2012;43:3387-3388. doi: 10.1161/STROKEAHA.112.671172.
10. Kang DW, Kwon SU, Yoo SH, Kwon KY, Choi CG, Kim SJ, et al. Early recurrent ischemic lesions on diffusion-weighted imaging in symptomatic intracranial atherosclerosis. Arch Neurol. 2007;64:50-54. doi: 10.1001/archneur.64.1.50.
11. Kang DW, Lattimore SU, Latour LL, Warach S. Silent ischemic lesion recurrence on magnetic resonance imaging predicts subsequent clinical vascular events. Arch Neurol. 2006;63:1730-1733. doi: 10.1001/ archneur.63.12.1730.
12. Warach S. Use of diffusion and perfusion magnetic resonance imaging as a tool in acute stroke clinical trials. Curr Control Trials Cardiovasc Med. 2001;2:38-44.
13. Kang DW, Latour LL, Chalela JA, Dambrosia JA, Warach S. Early and late recurrence of ischemic lesion on MRI: evidence for a prolonged stroke-prone state? Neurology. 2004;63:2261-2265.
14. Savcic M, Hauert J, Bachmann F, Wyld PJ, Geudelin B, Cariou R. Clopidogrel loading dose regimens: kinetic profile of pharmacodynamic response in healthy subjects. Semin Thromb Hemost. 1999;25(suppl 2):15-19.
15. Kennedy J, Hill MD, Ryckborst KJ, Eliasziw M, Demchuk AM, Buchan AM; FASTER Investigators. Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomised controlled pilot trial. Lancet Neurol. 2007;6:961-969. doi: 10.1016/ S1474-4422(07)70250-8.
16. Geeganage CM, Diener HC, Algra A, Chen C, Topol EJ, Dengler R, et al; Acute Antiplatelet Stroke Trialists Collaboration. Dual or mono antiplatelet therapy for patients with acute ischemic stroke or transient ischemic attack: systematic review and meta-analysis of randomized controlled trials. Stroke. 2012;43:1058-1066. doi: 10.1161/ STROKEAHA.111.637686.
17. Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK; Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med. 2001;345:494-502. doi: 10.1056/NEJMoa010746.
18. Sabatine MS, Cannon CP, Gibson CM, López-Sendón JL, Montalescot G, Theroux P, et al; CLARITY-TIMI 28 Investigators. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. N Engl J Med. 2005;352:1179-1189. doi: 10.1056/NEJMoa050522.
19. Markus HS, Droste DW, Kaps M, Larrue V, Lees KR, Siebler M, et al. Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using doppler embolic signal detection: the Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) trial. Circulation. 2005;111:2233-2240. doi: 10.1161/01.CIR.0000163561.90680.1C.
20. Wong KS, Chen C, Fu J, Chang HM, Suwanwela NC, Huang YN, et al; CLAIR Study Investigators. Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): a randomised, open-label, blinded-endpoint trial. Lancet Neurol. 2010;9:489-497. doi: 10.1016/ S1474-4422(10)70060-0.
21. Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, et al; Warfarin-Aspirin Symptomatic Intracranial Disease Trial Investigators. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med. 2005;352:1305-1316. doi: 10.1056/NEJMoa043033.
22. Chimowitz MI, Lynn MJ, Derdeyn CP, Turan TN, Fiorella D, Lane BF, et al; SAMMPRIS Trial Investigators. Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med. 2011;365:993-1003. doi: 10.1056/NEJMoa1105335.
23. Liu L, Wong KS, Leng X, Pu Y, Wang Y, Jing J, et al; CHANCE Investigators. Dual antiplatelet therapy in stroke and ICAS: subgroup analysis of CHANCE. Neurology. 2015;85:1154-1162. doi: 10.1212/WNL.0000000000001972.
24. Longstreth WT Jr, Dulberg C, Manolio TA, Lewis MR, Beauchamp NJ Jr, O'Leary D, et al. Incidence, manifestations, and predictors of brain infarcts defined by serial cranial magnetic resonance imaging in the elderly: the Cardiovascular Health Study. Stroke. 2002;33:2376-2382.
25. Johnston SC, Easton JD, Farrant M, Barsan W, Battenhouse H, Conwit R, et al. Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) trial: rationale and design. Int J Stroke. 2013;8:479-483. doi: 10.1111/ijs.12129.